Buzaev, Igor V.,
Galimova, Rezida M.,
Nabiullina, Dinara I.,
Illarioshkin, Sergey N.,
Zagidullin, Naufal Sh.,
Safin, Shamil M. (2023) controlled prospective study included 94 patients: 27 with
essential tremor (ET) and 67 with tremor
. Sustainable development is associated with the reproduction of the
essential forces of man under the dominance
Sun, Pengfei,
Wang, Jiaqi,
Ilyasova, Tatiana,
Shumadalova, Alina,
Agaverdiev, Murad,
Wang, Chunlei (2023) –25 nucleotides in length. These molecules function as
essential regulators of gene expression by selectively
Sufianov, Albert,
Beilerli, Aferin,
Kudriashov, Valentin,
Ilyasova, Tatiana,
Wenjie, Bu,
Beylerli, Ozal (2023) RNAs delivery vectors is
essential for effective treatment of skin diseases. In recent years, significant
Gareev, Ilgiz,
de Jesus Encarnacion Ramirez, Manuel,
Goncharov, Evgeniy,
Ivliev, Denis,
Shumadalova, Alina,
Ilyasova, Tatiana,
Wang, Chunlei (2023) in innate immunity is
essential for developing effective diagnostic tools and therapies for infectious
Nurgalieva, A.Kh.,
Bashkatov, S.A.,
Volkova, E.V.,
Petrova, S.G.,
Takhirova, Z.R.,
Mustafin, R.N.,
Fedorova, Y.Y.,
Prokofyeva, D.S.,
Khusnutdinova, E.K. (2023) essential, which will allow using additional educational technologies as early as possible, thereby
Rafikova, G.,
Piatnitskaia, S.,
Shapovalova, E.,
Chugunov, S.,
Kireev, V.,
Ialiukhova, D.,
Bilyalov, A.,
Pavlov, V.,
Kzhyshkowska, J. (2023) of corrosion and general biocompatibility. The immuno-compatibility
of an implant
essentially depends
Khidiyatova, Irina,
Khidiyatova, Indira,
Zinchenko, Rena,
Marakhonov, Andrey,
Karunas, Alexandra,
Avkhadeeva, Svetlana,
Aznzbaev, Marat,
Khusnutdinova, Elza (2023) pose challenges for early DNA diagnosis. To comprehensively address this problem, it is
essentialZhu, Weiwei,
Luo, Wu,
Han, Jibo,
Zhang, Qiuyan,
Ji, Lijun,
Samorodov, Aleksandr V.,
Pavlov, Valentin N.,
Zhuang, Zaishou,
Yang, Daona,
Yin, Lina,
Huang, Lijiang,
Liang, Guang (2023) response factor-88 (MyD88), an
essential adaptor protein in the toll-like receptor-4 (TLR4) pathway. Sch B